Merck Sharp & Dohme, Wilson Facility
Merck Sharp & Dohme, Wilson Facility appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0007-2016, Class II) was initiated on August 14, 2015.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0007-2016 | Class II | Vytorin (ezetimibe and simvastatin) tablets, 10 mg/20 mg, each tablet contains 10 mg ezetimibe and 2 | August 14, 2015 |